Integral Diagnostics (ASX:IDX) reported Tuesday that its operating earnings per share rose to AU$0.102 in the fiscal year 2025, from AU$0.077 a year earlier.

Analysts surveyed by FactSet expected earnings of AU$0.09 per share.

Revenue for the 12 months ended June 30 was AU$627.2 million, up from AU$469.7 million a year earlier. Analysts surveyed by FactSet expected AU$629.8 million.

The company expects fiscal 2026 replacement and growth capital expenditure of between AU$45 million to AU$55 million.

The board declared a final dividend of AU$0.04 per share, up from AU$0.033 a year earlier, payable Oct. 3 to shareholders on record as of Sept. 1.